Yes. CBD has cannabinoid receptor-independent properties. For example....
What percentage of US medical marijuana legal states list cancer as a qualifying condition?
Cancer is listed as a qualifying condition in 100% of the US medical marijuana states....
Do Epidemiological studies show that cannabinoids are effective against Crohn’s disease?
Epidemiological studies indicate that as many as 15% of inflammatory bowel disease (IBD) patients may use cannabinoids to ameliorate some of their symptoms, including improvement in diarrhea, abdominal pain and appetite....
Some cancer patients use medical marijuana to treat various cancer-associated ailments. What are some of the ailments ameliorated by medical marijuana?
According to one study involving 96 cancer patients receiving supportive cancer care, the data support the safety and effectiveness of medical marijuana as a complementary option for improving pain control, appetite and quality of life for cancer patients....
What is Sativex®?
Sativex® is a buccal (oral) spray containing Δ-9-THC and CBD (2.7 mg Δ-9-THC and 2.5 mg CBD per spray) and it is indicated for spasticity and neuropathic pain in multiple sclerosis, and as adjunctive analgesia for moderate to severe cancer pain....
Do patients with chronic pelvic pain use cannabinoid-based products to ameliorate their symptoms?
Chronic pelvic pain affects up to 15% of women in the United States. The conclusions of a survey of 122 chronic pelvic pain female patients indicated that up to 23% report using cannabinoid-based products as an adjunct to their prescribed therapies....